Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michele Keryn Dilizia Insider Profile
4 Followers
Michele Keryn Dilizia, Chief Scientific Officer at Recce Pharmaceuticals Ltd., holds 3.54M shares in Recce Pharmaceuticals Ltd. (Ticker: AU:RCE). Most recently, Michele Keryn Dilizia Sold AU$175,000 shares of Recce Pharmaceuticals Ltd. on Jun 22, 2021 for an estimated value of 178.24K.
Michele Keryn Dilizia Recce Pharmaceuticals Ltd. (RCE)Chief Scientific Officer
Recce Pharmaceuticals Ltd. (RCE)
Chief Scientific Officer
Ranked #96,012 out of 98,042 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-320.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Michele Keryn Dilizia's holdings
Insider Roles
Chief Scientific Officer
Roles that Michele Keryn Dilizia holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 22, 2021 - Jun 22, 2022
Return:+14.30%
The most profitable trade made by Michele Keryn Dilizia
Michele Keryn Dilizia's Trading History
List of latest transactions for each holding click on a transaction to see Michele Keryn Dilizia's performance on stock
You May Also Like
Michele Keryn Dilizia insider profile FAQ
What is the percentage of profitable transactions made by Michele Keryn Dilizia?
The percentage of profitable transactions made by Michele Keryn Dilizia is 33%.
What is the average return per transaction made by Michele Keryn Dilizia?
The average return per transaction made by Michele Keryn Dilizia is -320.10%.
What stocks does Michele Keryn Dilizia hold?
Michele Keryn Dilizia holds: AU:RCE stocks.
What was Michele Keryn Dilizia’s latest transaction?
Michele Keryn Dilizia latest transaction was an Informative Sell of AU$178.24K.
What was Michele Keryn Dilizia's most profitable transaction?
Michele Keryn Dilizia’s most profitable transaction was an Informative Sell of AU:RCE stock on June 22, 2021. The return on the trade was 14.30%.
What is Michele Keryn Dilizia's role in Recce Pharmaceuticals Ltd.?
Michele Keryn Dilizia's role in Recce Pharmaceuticals Ltd. is Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.